Health Catalyst Inc. (HCAT) PT Lowered to $19 at Canaccord Genuity
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts HCAT Hot Sheet
Price: $1.44 --0%
Rating Summary:
9 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Rating Summary:
9 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Join SI Premium – FREE
Canaccord Genuity analyst Richard Close lowered the price target on Health Catalyst Inc. (NASDAQ: HCAT) to $19.00 (from $20.00) while maintaining a Buy rating.
You May Also Be Interested In
- Fortis Inc. (FTS:CN) (FTS) PT Raised to Cdn$90 at RBC Capital
- Eastman Chemical (EMN) PT Raised to $70 at RBC Capital
- Xometry Inc (XMTR) PT Raised to $117 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
